InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,565.70
(
-0.03%
)
US TECH 100
19,855.20
(
0.04%
)
Dow Jones
39,343.18
(
-0.08%
)
Brent Oil
85.55
(
-1.10%
)
Bitcoin
55,694.86
(
-0.27%
)
Post# of 252510
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ilpapa

Send PM Follow Ignore
Followers 6
Posts 1313
Boards Moderated 0
Alias Born 11/02/2003

ilpapa

Re: biomaven0 post# 110944

Thursday, 12/16/2010 7:43:58 AM

Thursday, December 16, 2010 7:43:58 AM

Post# of 252510
the FDA did not require "sameness" or complete characterization in approving MNTA's generic:


That can only be interpreted as favorable to TEVA's early approval chances and may explain why MNTA trades like the sword of Damocles was hanging over its head. When the sword falls, the negative effect may be limited.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up